Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Midcap ETF Vanguard | VO | Oct 31, 2024 | 262.71 | -1.17 |
MidCap Financial Investment | MFIC | Oct 31, 2024 | 13.37 | -0.37 |
Midcap Growth Alphadex First Trust | FNY | Oct 31, 2024 | 79.10 | -1.40 |
Midcap Growth ETF Vanguard | VOT | Oct 31, 2024 | 243.82 | -1.82 |
Midcap Value Alphadex First Trust | FNK | Oct 31, 2024 | 53.18 | -1.18 |
Midcap Value ETF Vanguard | VOE | Oct 31, 2024 | 165.98 | -0.65 |
Middleby | MIDD | Oct 31, 2024 | 129.70 | -7.61 |
Middlefield Banc | MBCN | Oct 31, 2024 | 28.24 | -0.91 |
Middlesex Water | MSEX | Oct 31, 2024 | 61.19 | -2.06 |
Midland States Bancorp | MSBI | Oct 31, 2024 | 24.81 | -0.96 |
Midland States Bancorp Pref A | MSBIP | Oct 31, 2024 | 25.30 | +0.78 |
MidWestOne Financial Group | MOFG | Oct 31, 2024 | 28.94 | -3.08 |
Milestone Pharmaceuticals | MIST | Oct 31, 2024 | 1.45 | +0.69 |
Milestone Scientific | MLSS | Oct 31, 2024 | 0.80 | 0.00 |
Mill City Ventures | MCVT | Oct 31, 2024 | 2.06 | 0.00 |
Millennium Group International | MGIH | Oct 31, 2024 | 1.44 | -8.86 |
Miller Industries | MLR | Oct 31, 2024 | 65.64 | -2.55 |
Miller/Howard High Income Equity Fund | HIE | Oct 31, 2024 | 12.28 | +0.08 |
MillerKnoll | MLKN | Oct 31, 2024 | 22.36 | -2.82 |
Millicom International Cellular | TIGO | Oct 31, 2024 | 27.56 | -0.86 |
MiMedx Group | MDXG | Oct 31, 2024 | 6.85 | +20.39 |
MIND C.T.I. | MNDO | Oct 31, 2024 | 1.96 | -1.26 |
Mind Technology | MIND | Oct 31, 2024 | 3.58 | 0.00 |
MindMed | MNMD | Oct 31, 2024 | 6.30 | -0.63 |
Minerals Technologies | MTX | Oct 31, 2024 | 75.29 | -1.67 |
Mineralys Therapeutics | MLYS | Oct 31, 2024 | 13.38 | -2.90 |
Minerva Neurosciences | NERV | Oct 31, 2024 | 2.40 | -1.44 |
Mingteng International | MTEN | Oct 31, 2024 | 8.89 | +2.77 |
MingZhu Logistics | YGMZ | Oct 31, 2024 | 1.27 | -8.27 |
MINISO Group ADR | MNSO | Oct 31, 2024 | 19.92 | -1.24 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.